(Q33611123)

28 July 2017

1 reference

title

Pathogenesis of toxoplasmic retinochoroiditis (English)

1 reference

28 July 2017

Roberts F

1

1 reference

28 July 2017

McLeod R

series ordinal

2

1 reference

28 July 2017

publication date

1 February 1999

1 reference

28 July 2017

published in

Trends in Parasitology

1 reference

28 July 2017

volume

15

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

51-57

1 reference

Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

The resistance of the encysted form of Toxoplasma gondii.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Eye manifestations of congenital toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Results of 20-year follow-up of congenital toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

1 reference

7 January 2021

Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

An unusually high prevalence of ocular toxoplasmosis in southern Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis. Part I: The localization and morphology of Toxoplasma cysts in the retina

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Prenatal diagnosis of congenital toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Diagnosis of toxoplasmosis in patients with AIDS by isolation of the parasite from the blood

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Ocular Toxoplasmosis in an Adult Receiving Long-Term Corticosteroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

CONNATAL OCULAR TOXOPLASMOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Studies on experimental ocular toxoplasmosis in the rabbit. II. Attempts to stimulate recurrences by local trauma, epinephrine, and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Protective role of nitric oxide in ocular toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Recovery of toxoplasma from a human eye

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Retinal vasculitis in ocular toxoplasmosis in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Immunoregulatory mechanisms of the eye

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

The role of FasL-induced apoptosis in immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

The role of nitric oxide in uveitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Role of nitric oxide (NO) in ocular inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Human retinal pigmented epithelial cells produce nitric oxide in response to cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

HLA typing in congenital toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Virulent strains of Toxoplasma gondii comprise a single clonal lineage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Experimental ocular toxoplasmosis in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

The role of hypersensitivity reactions to toxoplasma antigens in experimental ocular toxoplasmosis in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

TREATMENT OF EXPERIMENTAL OCULAR TOXOPLASMOSIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

A study of cataract in murine congenital toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2898%2901377-5

7 January 2021

10.1016/S0169-4758(98)01377-5

Identifiers

DOI

1 reference

28 July 2017

1 reference